143 related articles for article (PubMed ID: 23622890)
1. [Lethal enterovirus myocarditis associated with rituximab and chemotherapy for follicular lymphoma].
Alonso JJ; Cánovas A; Rubio G
Med Clin (Barc); 2013 Nov; 141(10):459-60. PubMed ID: 23622890
[No Abstract] [Full Text] [Related]
2. Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012.
Kassab S; Saghi T; Boyer A; Lafon ME; Gruson D; Lina B; Fleury H; Schuffenecker I
Emerg Infect Dis; 2013 Aug; 19(8):1345-7. PubMed ID: 23880543
[No Abstract] [Full Text] [Related]
3. Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma.
Bermúdez A; Marco F; Conde E; Mazo E; Recio M; Zubizarreta A
Haematologica; 2000 Aug; 85(8):894-5. PubMed ID: 10942955
[No Abstract] [Full Text] [Related]
4. Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study.
Witzens-Harig M; Foá R; Di Rocco A; van Hazel G; Chamone DF; Rowe JM; Arcaini L; Poddubnaya I; Ho AD; Ivanova V; Vranovsky A; Thurley D; Oertel S
Ann Hematol; 2014 Oct; 93(10):1717-24. PubMed ID: 24824768
[TBL] [Abstract][Full Text] [Related]
5. Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy.
Ganjoo KN; Raman R; Sobel RA; Pinto HA
Leuk Lymphoma; 2009 Apr; 50(4):673-5. PubMed ID: 19373672
[No Abstract] [Full Text] [Related]
6. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
[TBL] [Abstract][Full Text] [Related]
7. Maintenance rituximab should be considered for patients with follicular lymphoma.
Barr PM
Clin Adv Hematol Oncol; 2014 Aug; 12(8):541-3. PubMed ID: 25356579
[No Abstract] [Full Text] [Related]
8. Severe anemia during rituximab maintenance therapy for follicular lymphoma.
Liapis K; Harhalakis N; Stefanou G; Apostolidis J
J Clin Oncol; 2012 Mar; 30(8):e95-6. PubMed ID: 22231048
[No Abstract] [Full Text] [Related]
9. Enteroviral infection in patients treated with rituximab for non-Hodgkin lymphoma: a case series and review of the literature.
Grisariu S; Vaxman I; Gatt M; Elias S; Avni B; Arad A; Pasvolsky O; Raanani P; Paltiel O
Hematol Oncol; 2017 Dec; 35(4):591-598. PubMed ID: 27734521
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma.
Kumar R; Galardy PJ; Dogan A; Rodriguez V; Khan SP
Pediatr Blood Cancer; 2011 Aug; 57(2):317-20. PubMed ID: 21462303
[TBL] [Abstract][Full Text] [Related]
11. Fatal disseminated enterovirus infection in a patient with follicular lymphoma undergoing obinutuzumab maintenance therapy.
Heger JM; Eichenauer DA; Kasper P; Böll B; Shimabukuro-Vornhagen A; Kochanek M
Eur J Haematol; 2019 Sep; 103(3):268-271. PubMed ID: 31211882
[TBL] [Abstract][Full Text] [Related]
12. Norovirus in immunocompromised patients.
Atmar J; Mullen E
Oncol Nurs Forum; 2013 Sep; 40(5):434-6. PubMed ID: 23989016
[No Abstract] [Full Text] [Related]
13. Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma.
McClanahan F; Hielscher T; Rieger M; Hensel M; Bentz M; Schmidt-Wolf I; Käbisch A; Salwender H; Dürk H; Staiger H; Mandel T; Neben K; Hillengass J; Leo E; Krämer A; Ho AD; Witzens-Harig M
Am J Hematol; 2012 Oct; 87(10):E68-71. PubMed ID: 22847344
[No Abstract] [Full Text] [Related]
14. Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkin's lymphoma and corrected with IVIG.
Saikia TK; Menon H; Advani SH
Ann Oncol; 2001 Oct; 12(10):1493-4. PubMed ID: 11762825
[No Abstract] [Full Text] [Related]
15. Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma.
Higo T; Miyagaki T; Nakamura F; Shinohara A; Asano H; Abe H; Senda N; Yoshizaki A; Fukayama M; Kurokawa M
Ann Hematol; 2015 Apr; 94(4):683-5. PubMed ID: 25199505
[No Abstract] [Full Text] [Related]
16. Rituximab with or without bevacizumab for the treatment of patients with relapsed follicular lymphoma.
Hainsworth JD; Greco FA; Raefsky EL; Thompson DS; Lunin S; Reeves J; White L; Quinn R; DeBusk LM; Flinn IW
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):277-83. PubMed ID: 24679633
[TBL] [Abstract][Full Text] [Related]
17. Cerebellar Cladophialophora bantiana infection in a patient with marginal zone lymphoma treated with immunochemotherapy including rituximab.
Hemmaway C; Laverse E; Nicholas M; Nagy Z
Br J Haematol; 2011 Aug; 154(4):423. PubMed ID: 21506941
[No Abstract] [Full Text] [Related]
18. Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma.
Goy A; Berger M; Ford P; Feldman T; Mato A; Bejot C; Fung HC
Leuk Lymphoma; 2014 Dec; 55(12):2932-4. PubMed ID: 24611663
[No Abstract] [Full Text] [Related]
19. Rituximab for follicular non-Hodgkin lymphoma.
Gajraj E; Chung H; Longson C; Stevens A
Lancet Oncol; 2008 Apr; 9(4):320-1. PubMed ID: 18405852
[No Abstract] [Full Text] [Related]
20. Early initial therapy of advanced follicular lymphoma: the need for vigilance.
Sweetenham JW; Freedman AS
Leuk Lymphoma; 2011 Mar; 52(3):355-7. PubMed ID: 21323517
[No Abstract] [Full Text] [Related]
[Next] [New Search]
